Oncology News

Various primary care physicians in North Carolina who examine patients with cirrhosis do not offer a screening for hepatocellular carcinoma, according to results from a recent study.

Patients with cirrhotomimetic hepatocellular carcinoma with clear cell tumor pathology and a confinement of the disease had higher survival rates and lower recurrence rates after liver transplantation compared with patients who had unclear pathology, according to data from a recent study.

Older individuals who followed strict dietary recommendations had a decreased risk for chronic liver disease mortality and hepatocellular carcinoma, according to study results.

Taiho Pharmaceutical Co., parent company of Taiho Oncology, recently announced its decision to terminate a phase 3 clinical trial of the angiogenesis inhibitor orantinib plus transcatheter arterial chemoembolization for the treatment of patients with unresectable hepatocellular carcinoma.

A phase 3 clinical trial is under way to study the safety and efficacy of photodynamic therapy with porfimer sodium to treat a rare form of bile duct cancer that currently has no other therapeutic options, according to a press release.

Results from a recent study post-hoc analysis indicated an increased overall survival rate among patients with primary liver cancer when treated with encapsulated doxorubicin enhanced with lysolipid thermally sensitive liposomes in combination with radiofrequency ablation, according to a media release.

People of Māori descent in New Zealand who acquired horizontally transmitted hepatitis B virus had an increased risk for hepatocellular carcinoma and liver-related mortality, according to recent study results.

Incidence of liver cell and intrahepatic bile duct carcinomas increased over time among men and women in areas of deprivation in England, according to results from a new study.

Patients with hepatitis B virus infection treated with entecavir monotherapy remained at risk for developing hepatocellular carcinoma, according to study results.

Veterans with hepatitis C virus infection genotype 3 displayed an increased risk for cirrhosis and hepatocellular carcinoma compared with other genotypes, according to new study data.